A detailed history of Vanguard Group Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,932,057 shares of RZLT stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,932,057
Previous 1,618,036 19.41%
Holding current value
$10.6 Million
Previous $6.96 Million 34.68%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.13 - $5.31 $1.3 Million - $1.67 Million
314,021 Added 19.41%
1,932,057 $9.37 Million
Q2 2024

Aug 13, 2024

BUY
$2.29 - $5.79 $148,126 - $374,520
64,684 Added 4.16%
1,618,036 $6.96 Million
Q1 2024

May 10, 2024

BUY
$0.95 - $2.55 $138,415 - $371,535
145,700 Added 10.35%
1,553,352 $3.96 Million
Q4 2022

Feb 10, 2023

BUY
$1.38 - $2.84 $764 - $1,573
554 Added 0.04%
1,407,652 $2.91 Million
Q3 2022

Nov 14, 2022

SELL
$2.19 - $3.49 $72 - $115
-33 Reduced -0.0%
1,407,098 $3.86 Million
Q2 2022

Aug 12, 2022

BUY
$2.6 - $3.85 $2.76 Million - $4.09 Million
1,063,392 Added 309.36%
1,407,131 $4.55 Million
Q1 2022

May 13, 2022

BUY
$2.27 - $5.1 $23,835 - $53,549
10,500 Added 3.15%
343,739 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$4.21 - $7.61 $845,671 - $1.53 Million
200,872 Added 151.75%
333,239 $1.59 Million
Q3 2021

Nov 12, 2021

BUY
$7.45 - $13.66 $767,178 - $1.41 Million
102,977 Added 350.38%
132,367 $990,000
Q2 2021

Aug 13, 2021

BUY
$6.11 - $15.99 $179,572 - $469,946
29,390 New
29,390 $419,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $214M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.